Report - FARMACI AD ALTO COSTO E RISORSE LIMITATE: DETERMINANTI … · Oct 2015 Aug 2016 Nov 2016 IPILIMUMAB melanoma Mar 2011 Jul 2011 Feb 2013 PERTUZUMAB advanced breast cancer Jun 2012

Please pass captcha verification before submit form